Skip to main content
Caplight Logo









Genevoyager

Genevoyager

Private
WuhanHealthcare & Life Scienceshttps://genevoyager.ltd/

Last Round

Series A

Sep 12, 2023

Total Funding Raised

$32.77M

Company Overview

Genevoyager is a biotechnology company that provides one-stop Contract Research, Development, and Manufacturing Organization (CRO/CDMO) services for gene therapy products, specializing in large-scale viral vector preparation and delivery technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMOcontract research organizationCROadeno-associated virusAAVviral vector productiongene therapy manufacturingbaculovirus expression systembiotech outsourcingviral vector packagingcGMP manufacturingpreclinical researchstem cell servicesanimal disease models

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genevoyager Comparables

Compare Genevoyager with similar companies based on industry and business-model similarity.

Genevoyager comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ascend
83%
uBriGene Biosciences
82%
PackGene Biotech
82%

Genevoyager Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 12, 2023
Series AAug 1, 2023
Pre SeedJun 1, 2022

Genevoyager Investors

Notable investors and investment history

Genevoyager investors
InvestorRounds
Hongxin CapitalSeries A
SDIC Venture CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2022

    $5.2M raised in Pre Seed round.

Genevoyager Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genevoyager Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genevoyager's valuation, stock price, and market status.

Firmographic Details

HeadquartersWuhan
Year Founded2022
Last FundingSep 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?